top of page
BRIDGE
OFFICIAL TITLE: PHASE II TRIAL OF DURVALUMAB AND CHEMOTHERAPY INDUCTION FOLLOWED BY DURVALUMAB AND RADIOTHERAPY IN LARGE VOLUME STAGE III NSCLC (THE BRIDGE STUDY).
CLINICAL TRIAL DETAILS
STAGE III A-B-C (ACCORDING TO VERSION 8 OF THE INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER STAGING MANUAL IN THORACIC ONCOLOGY) NSCLC PATIENTS NOT ELIGIBLE FOR SURGERY OR CONCURRENT CHEMORADIATION AT DIAGNOSIS BECAUSE OF LARGE TUMOR VOLUMES.
THIS IS A MULTICENTRIC, OPEN LABEL, SINGLE ARM, SIMON 2 STAGES PHASE 2 TRIAL.
BRIDGE AT CLINICALTRIALS.GOV
TUMOR TYPE
PHASE
NSCLC
II
65
3
Spain, France
N
SITES
COUNTRY
STATUS
Recruitment
BRIDGE SITES
SPAIN
Vall d'Hebron Institute of Oncology (VHIO)
FRANCE
Gustave Roussy
ITALY
Institute Tumori Mario Negrini
bottom of page